Literature DB >> 15587667

Treatment planning and verification of proton therapy using spot scanning: initial experiences.

Antony J Lomax1, Terence Böhringer, Alessandra Bolsi, Doelf Coray, Frank Emert, Gudrun Goitein, Martin Jermann, Shixiong Lin, Eros Pedroni, Hanspeter Rutz, Otto Stadelmann, Beate Timmermann, Jorn Verwey, Damien C Weber.   

Abstract

Since the end of 1996, we have treated more than 160 patients at PSI using spot-scanned protons. The range of indications treated has been quite wide and includes, in the head region, base-of-skull sarcomas, low-grade gliomas, meningiomas, and para-nasal sinus tumors. In addition, we have treated bone sarcomas in the neck and trunk--mainly in the sacral area--as well as prostate cases and some soft tissue sarcomas. PTV volumes for our treated cases are in the range 20-4500 ml, indicating the flexibility of the spot scanning system for treating lesions of all types and sizes. The number of fields per applied plan ranges from between 1 and 4, with a mean of just under 3 beams per plan, and the number of fluence modulated Bragg peaks delivered per field has ranged from 200 to 45 000. With the current delivery rate of roughly 3000 Bragg peaks per minute, this translates into delivery times per field of between a few seconds to 20-25 min. Bragg peak weight analysis of these spots has shown that over all fields, only about 10% of delivered spots have a weight of more than 10% of the maximum in any given field, indicating that there is some scope for optimizing the number of spots delivered per field. Field specific dosimetry shows that these treatments can be delivered accurately and precisely to within +/-1 mm (1 SD) orthogonal to the field direction and to within 1.5 mm in range. With our current delivery system the mean widths of delivered pencil beams at the Bragg peak is about 8 mm (sigma) for all energies, indicating that this is an area where some improvements can be made. In addition, an analysis of the spot weights and energies of individual Bragg peaks shows a relatively broad spread of low and high weighted Bragg peaks over all energy steps, indicating that there is at best only a limited relationship between pencil beam weighting and depth of penetration. This latter observation may have some consequences when considering strategies for fast re-scanning on second generation scanning gantries.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15587667     DOI: 10.1118/1.1779371

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  64 in total

1.  Tumor control and QoL outcomes of very young children with atypical teratoid/rhabdoid tumor treated with focal only chemo-radiation therapy using pencil beam scanning proton therapy.

Authors:  Damien C Weber; Carmen Ares; Robert Malyapa; Francesca Albertini; Gabriele Calaminus; Ulrike Kliebsch; Lorentzos Mikroutsikos; Petra Morach; Alessandra Bolsi; Tony Lomax; Ralf Schneider
Journal:  J Neurooncol       Date:  2014-11-02       Impact factor: 4.130

2.  Verification of proton range, position, and intensity in IMPT with a 3D liquid scintillator detector system.

Authors:  L Archambault; F Poenisch; N Sahoo; D Robertson; A Lee; M T Gillin; R Mohan; S Beddar
Journal:  Med Phys       Date:  2012-03       Impact factor: 4.071

3.  A parameter study of pencil beam proton dose distributions for the treatment of ocular melanoma utilizing spot scanning.

Authors:  Kenneth Sutherland; Satoshi Miyajima; Hiroyuki Date; Hiroki Shirato; Masayori Ishikawa; Masao Murakami; Mitsuru Yamagiwa; Paul Bolton; Toshiki Tajima
Journal:  Radiol Phys Technol       Date:  2009-09-19

4.  Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute.

Authors:  Damien C Weber; Shahed Badiyan; Robert Malyapa; Francesca Albertini; Alessandra Bolsi; Antony J Lomax; Ralf Schneider
Journal:  Neuro Oncol       Date:  2015-08-30       Impact factor: 12.300

5.  Four-dimensional radiotherapeutic dose calculation using biomechanical respiratory motion description.

Authors:  Petru Manescu; Hamid Ladjal; Joseph Azencot; Michael Beuve; Etienne Testa; Behzad Shariat
Journal:  Int J Comput Assist Radiol Surg       Date:  2013-09-01       Impact factor: 2.924

6.  Randomized controlled trials in health technology assessment: overkill or overdue?

Authors:  Søren M Bentzen
Journal:  Radiother Oncol       Date:  2008-01-30       Impact factor: 6.280

7.  Clinical characterization of a proton beam continuous uniform scanning system with dose layer stacking.

Authors:  J B Farr; A E Mascia; W C Hsi; C E Allgower; F Jesseph; A N Schreuder; M Wolanski; D F Nichiporov; V Anferov
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

8.  Use of treatment log files in spot scanning proton therapy as part of patient-specific quality assurance.

Authors:  Heng Li; Narayan Sahoo; Falk Poenisch; Kazumichi Suzuki; Yupeng Li; Xiaoqiang Li; Xiaodong Zhang; Andrew K Lee; Michael T Gillin; X Ronald Zhu
Journal:  Med Phys       Date:  2013-02       Impact factor: 4.071

9.  Integrated beam orientation and scanning-spot optimization in intensity-modulated proton therapy for brain and unilateral head and neck tumors.

Authors:  Wenbo Gu; Daniel O'Connor; Dan Nguyen; Victoria Y Yu; Dan Ruan; Lei Dong; Ke Sheng
Journal:  Med Phys       Date:  2018-03-01       Impact factor: 4.071

10.  Reduction of the secondary neutron dose in passively scattered proton radiotherapy, using an optimized pre-collimator/collimator.

Authors:  David J Brenner; Carl D Elliston; Eric J Hall; Harald Paganetti
Journal:  Phys Med Biol       Date:  2009-09-24       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.